1 Bombieri C, Claustres M, De Boeck K, et al. Recommendations for the classification of diseases as CFTR-related disorders.
J Cyst Fibros. 2011;10 Suppl 2:S86–S102.
2 De Boeck K, Wilschanski M, Castellani C, et al. Cystic fibrosis: terminology and diagnostic algorithms. Thorax. 2006;61:627–35.
3 Ruegg CS, Kuehni CE, Gallati S, et al. Neugeborenen-Screening auf Cystische Fibrose – Evaluation nach einem Jahr. Paediatrica.
2013;24:24–8.
4 Munck A, Mayell SJ, Winters V et al. Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening. J Cyst Fibros. 2015;
14:706–13.
5 Kerem E, Conway S, Elborn S, Heijerman H. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros. 2005;4:7–26.
6 Sykes J, Stanojevic S, Goss CH, et al. A standardized approach to estimating survival statistics for population-based cystic fibrosis registry cohorts. J Clin Epidemiol. 2016;70:206–213.
7 Tuchman L, Schwartz M. Health outcomes associated with transition from pediatric to adult cystic fibrosis care.
Pediatrics. 2013;132:847–53.
8 Suri R, Wallis C, Bush A, et al. A comparative study of hypertonic saline, daily and alternate-day rhDNase in children with cystic fibrosis. Health Technol Assessment. 2002;6:1–69.
9 Ramsey BW, Davies J, McElvaney N, Tullis E, Bell SC, Drevínek P, et al. A CFTR potentiator in patients with cystic fibrosis and G551D mutation. N Engl J Med. 2011;365:1663–72.
10 Davies JC, Cunningham S, Harris WT, et al. Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study. Lancet Respir Med. 2016;4:107–15.
11 Wainwright CE, Elborn JS, Ramsey BW, et al. Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR.
N Engl J Med. 2015;373:220–31.
12 Mott LS, Park J, Murray CP, et al. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax. 2012;67:509–16.
13 Mika M, Korten I, Qi W, Regamey N, Frey U, Casaulta C,
SCILD study group. The nasal microbiota in infants with cystic fibrosis in the first year of life: a prospective cohort study.
Lancet Respir Med. 2016;4:627–35.
14 Hayes D Jr, Glanville AR, McGiffin D, et al. Age-related survival disparity associated with lung transplantation in cystic fibrosis: An analysis of the registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2016;35:1108–15.